122 related articles for article (PubMed ID: 15772575)
1. [Oxidative stress in bronchopulmonary disease: contribution of N-acetylcysteine (NAC)].
Guerin JC; Leophonte P; Lebas FX; Liard F; Terrioux P; Boulanger P
Rev Pneumol Clin; 2005 Feb; 61(1 Pt 1):16-21. PubMed ID: 15772575
[TBL] [Abstract][Full Text] [Related]
2. Oxidative stress and respiratory system: pharmacological and clinical reappraisal of N-acetylcysteine.
Santus P; Corsico A; Solidoro P; Braido F; Di Marco F; Scichilone N
COPD; 2014 Dec; 11(6):705-17. PubMed ID: 24787454
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological investigation on the anti-oxidant and anti-inflammatory activity of N-acetylcysteine in an ex vivo model of COPD exacerbation.
Cazzola M; Calzetta L; Facciolo F; Rogliani P; Matera MG
Respir Res; 2017 Jan; 18(1):26. PubMed ID: 28118826
[TBL] [Abstract][Full Text] [Related]
4. Oxidation pathway and exacerbations in COPD: the role of NAC.
Matera MG; Calzetta L; Cazzola M
Expert Rev Respir Med; 2016; 10(1):89-97. PubMed ID: 26567752
[TBL] [Abstract][Full Text] [Related]
5. Characterization of N-acetylcysteine and ambroxol in anti-oxidant therapy.
Gillissen A; Nowak D
Respir Med; 1998 Apr; 92(4):609-23. PubMed ID: 9659525
[TBL] [Abstract][Full Text] [Related]
6. Attenuation of bleomycin-induced lung injury and oxidative stress by N-acetylcysteine plus deferoxamine.
Teixeira KC; Soares FS; Rocha LG; Silveira PC; Silva LA; Valença SS; Dal Pizzol F; Streck EL; Pinho RA
Pulm Pharmacol Ther; 2008; 21(2):309-16. PubMed ID: 17904883
[TBL] [Abstract][Full Text] [Related]
7. Oxidative stress and regulation of glutathione in lung inflammation.
Rahman I; MacNee W
Eur Respir J; 2000 Sep; 16(3):534-54. PubMed ID: 11028671
[TBL] [Abstract][Full Text] [Related]
8. High concentration of antioxidants N-acetylcysteine and mitoquinone-Q induces intercellular adhesion molecule 1 and oxidative stress by increasing intracellular glutathione.
Mukherjee TK; Mishra AK; Mukhopadhyay S; Hoidal JR
J Immunol; 2007 Feb; 178(3):1835-44. PubMed ID: 17237434
[TBL] [Abstract][Full Text] [Related]
9. The role for N-acetylcysteine in the management of COPD.
Dekhuijzen PN; van Beurden WJ
Int J Chron Obstruct Pulmon Dis; 2006; 1(2):99-106. PubMed ID: 18046886
[TBL] [Abstract][Full Text] [Related]
10. Dual behavior of N-acetylcysteine during ethanol-induced oxidative stress in embryonic chick brains.
Bauer AK; Fitzgerald M; Ladzinski AT; Lenhart Sherman S; Maddock BH; Norr ZM; Miller RR
Nutr Neurosci; 2017 Oct; 20(8):478-488. PubMed ID: 27219873
[TBL] [Abstract][Full Text] [Related]
11. Oxidative Stress and Inflammation in Hepatic Diseases: Therapeutic Possibilities of N-Acetylcysteine.
de Andrade KQ; Moura FA; dos Santos JM; de Araújo OR; de Farias Santos JC; Goulart MO
Int J Mol Sci; 2015 Dec; 16(12):30269-308. PubMed ID: 26694382
[TBL] [Abstract][Full Text] [Related]
12. IL-17A-induced neutrophilic airway inflammation is mediated by oxidant-antioxidant imbalance and inflammatory cytokines in mice.
Nadeem A; Al-Harbi NO; Alfardan AS; Ahmad SF; AlAsmari AF; Al-Harbi MM
Biomed Pharmacother; 2018 Nov; 107():1196-1204. PubMed ID: 30257333
[TBL] [Abstract][Full Text] [Related]
13. N-acetylcysteine prevents lung inflammation after short-term inhalation exposure to concentrated ambient particles.
Rhoden CR; Lawrence J; Godleski JJ; González-Flecha B
Toxicol Sci; 2004 Jun; 79(2):296-303. PubMed ID: 15056806
[TBL] [Abstract][Full Text] [Related]
14. Effect of N-acetylcysteine supplementation on oxidative stress status and alveolar inflammation in people exposed to asbestos: a double-blind, randomized clinical trial.
Alfonso H; Franklin P; Ching S; Croft K; Burcham P; Olsen N; Reid A; Joyce D; de Klerk N; Musk AB
Respirology; 2015 Oct; 20(7):1102-7. PubMed ID: 26172395
[TBL] [Abstract][Full Text] [Related]
15. The effect of an oral anti-oxidant, N-Acetyl-cysteine, on inflammatory and oxidative markers in pulmonary sarcoidosis.
Hamzeh N; Li L; Barkes B; Huang J; Canono B; Gillespie M; Maier L; Day B
Respir Med; 2016 Mar; 112():106-11. PubMed ID: 26831541
[TBL] [Abstract][Full Text] [Related]
16. Repeated-Dose Oral N-Acetylcysteine in Parkinson's Disease: Pharmacokinetics and Effect on Brain Glutathione and Oxidative Stress.
Coles LD; Tuite PJ; Öz G; Mishra UR; Kartha RV; Sullivan KM; Cloyd JC; Terpstra M
J Clin Pharmacol; 2018 Feb; 58(2):158-167. PubMed ID: 28940353
[TBL] [Abstract][Full Text] [Related]
17. N-acetylcysteine attenuates kidney injury in rats subjected to renal ischaemia-reperfusion.
Nitescu N; Ricksten SE; Marcussen N; Haraldsson B; Nilsson U; Basu S; Guron G
Nephrol Dial Transplant; 2006 May; 21(5):1240-7. PubMed ID: 16390850
[TBL] [Abstract][Full Text] [Related]
18. Modulation of pneumotoxicity by cellular glutathione and precursors.
Cotgreave IA; Grafström RC; Moldéus P
Bull Eur Physiopathol Respir; 1986; 22(1):263s-266s. PubMed ID: 3697545
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotection induced by N-acetylcysteine against cytosolic glutathione depletion-induced Ca2+ influx in dorsal root ganglion neurons of mice: role of TRPV1 channels.
Nazıroğlu M; Ciğ B; Ozgül C
Neuroscience; 2013 Jul; 242():151-60. PubMed ID: 23545271
[TBL] [Abstract][Full Text] [Related]
20. N-acetyl cysteine reduces oxidative toxicity, apoptosis, and calcium entry through TRPV1 channels in the neutrophils of patients with polycystic ovary syndrome.
Köse SA; Nazıroğlu M
Free Radic Res; 2015 Mar; 49(3):338-46. PubMed ID: 25666878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
